Fulvestrant 250mg Injection

Fulvestrant 250mg Injection Specification

Storage
Dry Place

Appearance
Liquid

Usage
Hospital

Medicine Type
Anti Cancer

Dosage
250mg

Grade
Pharma

Fulvestrant 250mg Injection Trade Information

Minimum Order Quantity
100 Boxes

Supply Ability
5000 Boxes Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe

About Fulvestrant 250mg Injection

Fulvestrant 250mg Injection is a medication used in the treatment of hormone receptor-positive (HR+), HER2-negative advanced breast cancer in postmenopausal women. This works by binding to estrogen receptors (ERs) in breast cancer cells, resulting in the degradation of the ERs and preventing them from activating gene transcription. It belongs to a class of drugs known as selective estrogen receptor degraders (SERDs). Fulvestrant 250mg Injection is effective in slowing down the progression of HR+ metastatic breast cancer in postmenopausal women, both as a first-line treatment and in patients who have progressed after prior endocrine therapy.

Specification

Brand	Faslodex 250mg Injection
Packing	5 ml in 1 vial
Strength	250 mg
Manufactured By	AstraZeneca
Country of Origin	Made in India

Targeted Therapy for Advanced Breast Cancer

Fulvestrant 250mg Injection is designed for precision in treating hormone receptor-positive breast cancer. Its mechanism disrupts cancer cell growth, offering an effective solution in the management of advanced or metastatic disease, predominantly in postmenopausal women.

Strict Quality Standards and Storage

Manufactured to pharmaceutical-grade standards, Fulvestrant maintains high efficacy and safety profiles. The liquid formulation should always be stored in a dry place, away from light and moisture, preserving its therapeutic benefits.

FAQ's of Fulvestrant 250mg Injection:

Q: How is Fulvestrant 250mg Injection administered in a hospital setting?

A: Fulvestrant 250mg Injection is administered by a healthcare professional, usually via intramuscular injection into the buttocks. It is delivered in hospital or clinical environments to ensure correct dosage and monitoring.

Q: What medical conditions is Fulvestrant 250mg Injection prescribed for?

A: This medication is primarily prescribed for hormone receptor-positive advanced or metastatic breast cancer, especially in postmenopausal women who have experienced progression following anti-estrogen therapy.

Q: When should Fulvestrant 250mg Injection be used during treatment?

A: The injection is used as per a physician's guidance, often as a second-line treatment after other hormonal therapies have been tried. Dosage schedules and duration are tailored to individual patient needs.

Q: Where can Fulvestrant 250mg Injection be procured in India?

A: Fulvestrant 250mg Injection is supplied by exporters and wholesalers across India and is mainly intended for institutional use in hospitals and medical centers.

Q: What is the process of storing Fulvestrant 250mg Injection?

A: The injection should be kept in a dry place, away from direct sunlight and moisture, and stored according to the pharmaceutical guidelines to maintain its quality and effectiveness.

Q: How does Fulvestrant 250mg Injection benefit patients with breast cancer?

A: By targeting the estrogen receptor, Fulvestrant slows down or stops the growth of certain types of breast cancer cells, offering improved disease management and quality of life for eligible patients.